The offer on the table for #Italianpharma group #Recordati by #privateequity firms #CVC and #GBL undervalues the company and is unfair to minority #shareholders, according to #hedgefund #Palliser, which is leading a pushback against the deal.
@pharmaphorum.bsky.social